Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	84.85	98.30	53.18
Graham Fair Price	-17.10	14.17	17.09
PEG	-92.75	0.03	-0.46
Price/Book	-10.28	0.17	0.19
Price/Cash Flow	-4.14	-5.71	-5.48
Prices/Earnings	28.23	-5.62	4.38
Price/Sales	-5.93	0.84	0.90
Price/FCF	-4.14	-5.71	-5.48
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-15.64	0.24	0.29
Operating Margin	-78.61	-0.01	0.05
ROA	-30.59	< 0.005	< 0.005
ROE	0.01	< 0.005	-30.03
ROIC	< 0.005	< 0.005	-82.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	58.47
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.36	-1.20	-232.19
EPS QOQ	-0.10	-1.68	-1668.42
FCF QOQ	-2.79	0.14	-94.82
Revenue QOQ	-0.01	-0.05	-361.32
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.82	18.35	15.94
Days Sales Outstanding (DSO)	78.43	19.50	-75.14
Inventory Turnover	5.69	4.91	-13.75
Debt/Capitalization	0.57	0.57	0.36
Quick Ratio	0.46	0.32	-31.19
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	34.54	34.23	-0.89
Cash	3.35	1.94	-42.07
Capex	-2.35	-1.72	27.01
Free Cash Flow	-1.20	-1.03	14.61
Revenue	7.34	6.94	-5.48
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.64	0.54	-15.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	46.21	86.74	87.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating